DE69816520D1 - Behandlung von durch Einzeller verursachte Infektionen - Google Patents

Behandlung von durch Einzeller verursachte Infektionen

Info

Publication number
DE69816520D1
DE69816520D1 DE69816520T DE69816520T DE69816520D1 DE 69816520 D1 DE69816520 D1 DE 69816520D1 DE 69816520 T DE69816520 T DE 69816520T DE 69816520 T DE69816520 T DE 69816520T DE 69816520 D1 DE69816520 D1 DE 69816520D1
Authority
DE
Germany
Prior art keywords
treatment
infections caused
unicellular organisms
unicellular
organisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69816520T
Other languages
English (en)
Other versions
DE69816520T2 (de
Inventor
David Hamilton Young
Enrique Luis Michelotti
Thomas David Edlind
Santosh Kumar Katiyar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALLEGHENY UNIVERSITY OF HE
Original Assignee
ALLEGHENY UNIVERSITY OF HE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALLEGHENY UNIVERSITY OF HE filed Critical ALLEGHENY UNIVERSITY OF HE
Application granted granted Critical
Publication of DE69816520D1 publication Critical patent/DE69816520D1/de
Publication of DE69816520T2 publication Critical patent/DE69816520T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69816520T 1997-05-01 1998-04-27 Behandlung von durch Einzeller verursachte Infektionen Expired - Fee Related DE69816520T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4526797P 1997-05-01 1997-05-01
US45267P 1997-05-01

Publications (2)

Publication Number Publication Date
DE69816520D1 true DE69816520D1 (de) 2003-08-28
DE69816520T2 DE69816520T2 (de) 2004-04-15

Family

ID=21936913

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816520T Expired - Fee Related DE69816520T2 (de) 1997-05-01 1998-04-27 Behandlung von durch Einzeller verursachte Infektionen

Country Status (13)

Country Link
US (1) US6107316A (de)
EP (1) EP0878192B1 (de)
JP (1) JPH10316563A (de)
KR (1) KR100526093B1 (de)
CN (1) CN1181818C (de)
AR (1) AR012640A1 (de)
AU (1) AU749643B2 (de)
BR (1) BR9806516A (de)
CA (1) CA2235902C (de)
DE (1) DE69816520T2 (de)
ES (1) ES2203889T3 (de)
TW (1) TW593230B (de)
ZA (1) ZA983331B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
EP1229028A1 (de) * 1996-06-28 2002-08-07 Dow AgroSciences LLC Heterocyclische N-Acetonylbenzamide und ihre Verwendung als Fungizide
JP4143787B2 (ja) 1999-07-28 2008-09-03 味の素株式会社 α−アミノハロメチルケトン誘導体の製造方法
AU6597300A (en) * 1999-08-19 2001-03-19 Ishihara Sangyo Kaisha Ltd. Agents for controlling animal diseases caused by endoparasites
JP4064243B2 (ja) * 2000-11-06 2008-03-19 スルーズ サージカル システムズ、インク 生体組織検査装置
US6482982B1 (en) * 2001-03-09 2002-11-19 University Of Sciences Of Philadelphia Halogenated antituberculosis agents
US20030153864A1 (en) * 2001-10-16 2003-08-14 Bernard Chaffringeon Disposable device and method for transferring an active liquid into a body cavity
US8032347B2 (en) * 2001-11-01 2011-10-04 The University Of British Columbia Methods and apparatus for protein sequence analysis
EP1553831A4 (de) * 2002-06-17 2007-11-07 Dow Agrosciences Llc Verfahren zum screening fungitoxischer verbindungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3661991A (en) * 1969-05-29 1972-05-09 Rohm & Haas N-(1,1-dialkyl-3-chloroacetonyl) benzamides
US4863940A (en) * 1984-07-26 1989-09-05 Rohm And Haas N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
US4822902A (en) * 1984-07-26 1989-04-18 Rohm And Haas Company N-acetonylbenzamides and their use as fungicides
US5304572A (en) * 1992-12-01 1994-04-19 Rohm And Haas Company N-acetonylbenzamides and their use as fungicides
US5254584A (en) * 1992-12-18 1993-10-19 Rohm And Haas Company N-acetonylbenzamides and their use as fungicides
IL121789A (en) * 1996-10-03 2001-06-14 Rohm & Haas A medicinal product for inhibiting mammalian cell tumors

Also Published As

Publication number Publication date
ES2203889T3 (es) 2004-04-16
EP0878192A3 (de) 2000-04-19
AU749643B2 (en) 2002-06-27
TW593230B (en) 2004-06-21
CN1198330A (zh) 1998-11-11
BR9806516A (pt) 2000-04-11
AR012640A1 (es) 2000-11-08
DE69816520T2 (de) 2004-04-15
EP0878192A2 (de) 1998-11-18
KR100526093B1 (ko) 2006-01-27
EP0878192B1 (de) 2003-07-23
AU6359598A (en) 1998-11-05
CA2235902A1 (en) 1998-11-01
JPH10316563A (ja) 1998-12-02
ZA983331B (en) 1998-10-27
US6107316A (en) 2000-08-22
CN1181818C (zh) 2004-12-29
CA2235902C (en) 2004-07-06
KR19980086718A (ko) 1998-12-05

Similar Documents

Publication Publication Date Title
DE69831134D1 (de) Behandlung von wasser
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69621830T2 (de) Alpha-substituierte arylsulphonamidohydroxamsaüre als tnf-alpha und matrix-metalloproteinase-inhibitoren
DE69500089T2 (de) Behandlung von Geflügel
ATE260332T1 (de) Behandlung von textilien
DE69716647T2 (de) Biologische behandlung von gebrauchten kaustischen laugen
DE69608448D1 (de) Reduktion des biobewuchses
ATE300597T1 (de) Behandlung von geweben
ATE349216T1 (de) Behandlung von darmverstopfung
DE60118179D1 (de) Behandlung von zirkulierenden wassersystemen
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE346090T1 (de) Abgeschwaechte mikroorganismen fuer die behandlung von infektionen
DE69316203D1 (de) Elektrochemische behandlung von oberflächen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE69816520D1 (de) Behandlung von durch Einzeller verursachte Infektionen
DE69405711D1 (de) Behandlung von rueckstandsoel
ATE332144T1 (de) Behandlung von herzhypertrophie
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60103685D1 (de) Behandlung von Poriomania
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
TR199500775A2 (tr) Suyun isleme tabi tutulmasi.
DE69801423D1 (de) Behandlung von organische säuren enthaltenden abwasserströmen
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee